Cabot Brown - Net Worth and Insider Trading

Cabot Brown Net Worth

The estimated net worth of Cabot Brown is at least $2 Million dollars as of 2024-05-05. Cabot Brown is the Director of GW Pharmaceuticals PLC and owns about 7,200 shares of GW Pharmaceuticals PLC (GWPH) stock worth over $2 Million. Details can be seen in Cabot Brown's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Cabot Brown has not made any transactions after 2021-03-18 and currently still holds the listed stock(s).

Transaction Summary of Cabot Brown

To

Cabot Brown Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cabot Brown owns 1 companies in total, including GW Pharmaceuticals PLC (GWPH) .

Click here to see the complete history of Cabot Brown’s form 4 insider trades.

Insider Ownership Summary of Cabot Brown

Ticker Comapny Transaction Date Type of Owner
GWPH GW Pharmaceuticals PLC 2021-03-18 director

Cabot Brown Latest Holdings Summary

Cabot Brown currently owns a total of 1 stock. Cabot Brown owns 7,200 shares of GW Pharmaceuticals PLC (GWPH) as of March 18, 2021, with a value of $2 Million.

Latest Holdings of Cabot Brown

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GWPH GW Pharmaceuticals PLC 2021-03-18 7,200 218.96 1,576,512

Holding Weightings of Cabot Brown


Cabot Brown Form 4 Trading Tracker

According to the SEC Form 4 filings, Cabot Brown has made a total of 3 transactions in GW Pharmaceuticals PLC (GWPH) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in GW Pharmaceuticals PLC is the sale of 4,020 shares on March 18, 2021, which brought Cabot Brown around $72,159.

Insider Trading History of Cabot Brown

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cabot Brown Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Cabot Brown Ownership Network

Ownership Network List of Cabot Brown

No Data

Ownership Network Relation of Cabot Brown


Cabot Brown Owned Company Details

What does GW Pharmaceuticals PLC do?

Who are the key executives at GW Pharmaceuticals PLC?

Cabot Brown is the director of GW Pharmaceuticals PLC. Other key executives at GW Pharmaceuticals PLC include Chief Legal Officer Douglas B. Snyder , Chief Medical Officer Volker Knappertz , and Secretary Adam D. George .

GW Pharmaceuticals PLC (GWPH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of GW Pharmaceuticals PLC (GWPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GW Pharmaceuticals PLC (GWPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

GW Pharmaceuticals PLC (GWPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

GW Pharmaceuticals PLC Insider Transactions

No Available Data

Cabot Brown Mailing Address

Above is the net worth, insider trading, and ownership report for Cabot Brown. You might contact Cabot Brown via mailing address: Sovereign House, Vision Park, Histon Cambridge X0 Cb24 9bz.

Discussions on Cabot Brown

No discussions yet.